Global Circulating Tumor Cells Market Report By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods And CTC Analysis), By Application (Multiple chromosome abnormalities, RNA profiling, Protein expression, Cellular communication And Others), By End-Use (Research & academic institutes, Hospital & clinics And Diagnostic centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030
The global demand for Circulating Tumor Cells Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
A circulating tumor cell (CTC) is a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation. CTCs can extravasate and become seeds for the subsequent growth of additional tumors (metastases) in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths. The detection and analysis of CTCs can assist early patient prognoses and determine appropriate tailored treatments. Currently, there is one FDA-approved method for CTC detection, CellSearch, which is used to diagnose breast, colorectal and prostate cancer.
High growth in attributed to rising prevalence of cancer globally. As per research, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer, fuelling the market growth. Furthermore, technological advancement in biomedical imaging and bioengineering processes will further augment market growth. On the flip side, lack of awareness among the population hamper the market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of circulating tumor cells.
The entire circulating tumor cells market has been sub-categorized into technology, application, and end-use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
CTC Detection & Enrichment Methods
CTC Direct Detection Methods
Multiple Chromosome Abnormalities
Research & Academic Institutes
Hospital & Clinics
This section covers regional segmentation which accentuates on current and future demand for circulating tumor cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Circulating Tumor Cells Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the circulating tumor cells market include Aviva Biosciences, Advanced Cell Diagnostics Inc., Biocept Inc., LungLife AI Inc., Creatv Micro Tech, Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Precision for Medicine and Qiagen NV. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Circulating Tumor Cells Market
2.2. Global Circulating Tumor Cells Market Snapshot
3 . CIRCULATING TUMOR CELLS – INDUSTRY ANALYSIS
3.2. Market Drivers of Circulating Tumor Cells Market
3.3. Market Restraints of Circulating Tumor Cells Market
3.4. Opportunities of Circulating Tumor Cells Market
3.5. Trends of Circulating Tumor Cells Market
3.6. Porter's Five Force Analysis of Circulating Tumor Cells Market
3.7. Circulating Tumor Cells Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Technology
3.7.2 Market Attractive Analysis by Application
3.7.3 Market Attractive Analysis by End-Use
3.7.4 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Circulating Tumor Cells Value Chain Analysis
4.2. Circulating Tumor Cells Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Circulating Tumor Cells Raw Material Manufactures List
4.2.3. Price Trend of Circulating Tumor Cells Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak on Circulating Tumor Cells Market
5.1.1. Direct Impact on Production